Verkazia is an oil-in-water cationic emulsion that works by inhibiting T-cell activation and reducing the level of immune cells and mediators. Verkazia ® (cyclosporine ophthalmic emulsion) 0.1% ...

Real-world outcomes from the PERSPECTIVE study showed long-term efficacy of cyclosporine A 0.1% cationic emulsion in controlling severe keratitis in patients with dry eye disease.The study was ...

Verkazia is an oil-in-water cationic emulsion that works by inhibiting T-cell activation and reducing the level of immune cells and mediators. The approval was based on data from 2 randomized, ...

With the FDA's approval last week of cyclosporine ophthalmic emulsion 0.1% (Verkazia), ophthalmologists now have another option to treat their patients, both adults and children, with vernal ...

The European Medicines Agency (EMA) has accepted Santen Pharmaceutical’s (Santen) marketing authorisation application (MAA) for use of STN1013001 (cationic emulsion of latanoprost 50μg/ml) for ...

Under a new distribution agreement with Santen SA, Bruder Healthcare will market Eyeleve MGD, the preservative-free ophthalmic emulsion previously sold in the U.S. as Retaine MGD, the company ...